This is because human kallikreins (PSA, i.e., hK3, and hK2, among others) are involved in the dedifferentiation of prostate cells, ensuring cell invasion and angiogenesis, among other things, which increases the risk of progression of the present cancer and metastasis. The gene discussed is KLK3; the disease is cancer.